Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aptevo Therapeutics
(APVO) Q3 2025
Earnings
APVO
Aug 11
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-87.8
-61.12
-34.43
-7.75
Details
Expected EPS
-83.2
Actual EPS
-8.4
Surprise EPS
74.8
Surprise Percent
+89.9%
Description
Aptevo Therapeutics (APVO) has reported earnings of -8.4 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login